Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The FDA approved Wegovy in 2024 to reduce cardiovascular death, heart attack, and stroke risk in adults with established cardiovascular disease and obesity
This option suits patients with moderate body composition goals, patients who want the convenience of one daily injection, and those who are not specifically targeting maximum visceral fat reduction
A safe serum range is 200350 ng/L, depending on age and clinical condition
We also checked medication sourcing basics, including whether clinicians oversee compounded GLP-1 injections dispensed from FDA-registered pharmacies
US$ 21.98
US$ 27.35
US$ 23.75
US$ 24.11
US$ 23.06
